The Middle East and Africa Continuous Glucose Monitoring (CGM) market is set for growth, driven by increasing diabetes rates, technological advancements, and healthcare awareness. Projected to rise ...
Medical device maker Dexcom on Thursday reiterated its full-year revenue forecast after beating Wall Street estimates for ...
DexCom has a well-established record of introducing the most precise sensors for use in its continuous glucose monitors. On the strength of its technology, DexCom has captured an impressive slice of ...
Landmark 10th Annual Awards Program Recognizes the Most Innovative Digital Health and Medical Technology Solutions Worldwide ...
MarketBeat on MSN
3 reasons analysts love DexCom
While GLP-1 agonists have grabbed investor attention for their potential as weight loss aids, these medicines also form a ...
Equity-Insider.com News Commentary - Here's the quiet shift in medtech right now: the global medical imaging market is on track to grow from $41.64 billion in 2024 to $67.87 billion by 2034[1], and ...
Explore India wearable medical device market growth across hospitals and homes, driven by remote monitoring, AI, and rising ...
So, Medtronic is shaking things up, especially with their diabetes division. They’re planning to split it off into its own ...
Sedentary behaviour is associated with an increased risk of cardiovascular disease and all-cause mortality in people with ...
MiniMed Group, Inc. (MiniMed; Nasdaq: MMED), a global leader in insulin delivery, announced Health Canada has licensed new ...
A smarter way to track how you actually feel.
“CGM is a powerful tool to characterize how diabetes drugs work in practice, and this work supports further research into the value of CGM, in conjunction with [A1c], as a guide to management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results